Karayiannides, Stelios http://orcid.org/0000-0002-7826-1302
Djupsjö, Catarina
Kuhl, Jeanette
Hofman-Bang, Claes
Norhammar, Anna
Holzmann, Martin J.
Lundman, Pia
Funding for this research was provided by:
Stockholms Läns Landsting
Karolinska Institute
Article History
Received: 28 March 2021
Accepted: 5 June 2021
First Online: 14 June 2021
Declarations
:
: This study was approved by the regional research ethics committee in Stockholm, Sweden (reg. no 2014/338-31/2 and 2018/1321-32).
: Not applicable.
: The authors declare that they have no conflicts of interest concerning this study. Dr. Karayiannides reports personal fees from Astra Zeneca, Boehringer Ingelheim and Novo Nordisk, outside the submitted work. Dr. Djupsjö, Dr. Kuhl and Dr. Hofman-Bang have nothing to disclose. Prof. Norhammar reports personal fees from Astra Zeneca, MSD, Boehringer Ingelheim, Lilly and Novo Nordisk, outside the submitted work. Prof. Holzmann reports personal fees from Idorsia, outside the submitted work. Dr. Lundman reports personal fees from Boehringer Ingelheim, Sanofi and Novo Nordisk, outside the submitted work.